Announcements & Disclosures
Quarterly Announcements & Disclosures
Quarterly Announcements & Disclosures
Quarterly Announcements & Disclosures
Notice of Board Meeting on 29th July 2019Proceedings of 14th Annual General MeetingVoting Results of 14th Annual General MeetingNotice of Board Meeting on 4th November 2019Related Party Disclosures for half year ended on 30th September 2019Update on Taclantis® Investor Presentation – Update on R&D PipelinePress Release – Audio Playback for Update on R&D Pipeline
Quarterly Announcements & Disclosures
Allotment of 6060606 equity shares on conversion of warrantsAchievement of milestone - commercialisation of XELPROS ™ Shareholding Pattern - 11th January 2019 POSTNotice of Board Meeting on 4th February 2019Receipt of Demand Order from the Office of Commissioner of GST & Central ExciseReturn of Product Rights by partner for ELEPSIA ™ XR 1000/1500mgMandatory Dematerialization for Transfer of Securities
Quarterly Announcements & Disclosures
Details of Independent Directors familiarisation Program - 2016-17Notice of Board Meeting on 5th May 2017Outcome of Board Meeting held on 5th May 2017Notice of EGM - 2nd June 2017Notice for the 12th Annual General MeetingUpdate on Elepsia XRTM (Levetiracetam extended-release tablets 1000 mg and 1500 mg) NDA
Quarterly Announcements & Disclosures
Notice - Completion of dispatch & remote e-voting at 11th AGMNotice of Board Meeting on 29th July 2016Press Release - Update on NCE and NDDS ProgramsProceedings of the 11th Annual General Meeting held on 29th July 2016 Voting Results of 11th Annual General MeetingPostal Ballot Notice and Form - August 2016News Paper Notice - Postal Ballot 2016Results of Postal Ballot 2016